K. Dunn

Therapeutic Drug Monitoring in Patients Coinfected with Human Immunodeficiency Virus and Disseminated Mycobacterium avium Complex

P. Skolnik, H. Hardy, Leyla Azis, 2011 .

Antiretroviral Adherence, Drug Resistance, and the Impact of Social Determinants of Health in HIV-1 Patients in the US

L. Mesana, H. Hardy, E. Y. Wong, 2020, AIDS and Behavior.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study

R. Bolan, M. Ramgopal, R. Nettles, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis

Shubin Sheng, H. Hardy, K. Dunn, 2021, HIV research & clinical practice.

Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.

R. Kagan, R. Nettles, H. Kaufman, 2019, AIDS research and human retroviruses.

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study

P. Lefebvre, M. Lafeuille, Aurélie Côté-Sergent, 2021, Journal of health economics and outcomes research.

Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus

P. Lefebvre, C. Benson, N. Tandon, 2019, Journal of managed care & specialty pharmacy.

Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV

P. Lefebvre, J. Pesa, N. Tandon, 2018, Journal of managed care & specialty pharmacy.

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage

P. Lefebvre, C. Benson, N. Tandon, 2019, Journal of managed care & specialty pharmacy.

Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks: Post hoc Analyses of AMBER and EMERALD

Nika Bejou, K. Dunn, B. Baugh, 2022, Journal of the International Association of Providers of AIDS Care.